Wilterding Mark
Chief Financial Officer
Wilterding Mark has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Wilterding Mark is listed as Chief Financial Officer at RxSight, Inc. Inside the rolling window, Wilterding Mark reported no open-market purchases and 1 open-market sale totaling $54K in RXST.
Companies traded
Other insiders at RXST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$54K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Wilterding Mark made?
Wilterding Mark has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Wilterding Mark trade?
Wilterding Mark has filed SEC Form 4 disclosures for 1 company, including RXST.
When was Wilterding Mark's most recent SEC Form 4 filing?
Wilterding Mark's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Wilterding Mark's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Wilterding Mark is listed as Chief Financial Officer.
What is Wilterding Mark's total buy and sell value in the current window?
Inside the rolling retention window, Wilterding Mark bought $0 and sold $54K based on SEC Form 4 filings.
What was Wilterding Mark's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,765 RXST shares on 2026-09-02, worth $54K, per SEC Form 4 filings.